Lauren M Wright1, Thor D Stein2,3,4,5, Gyungah Jun6,7, Jaeyoon Chung6,7, Kate McConnell1, Marissa Fiorello1, Nicole Siegel1, Steven Ness1, Weiming Xia5,8, Kelley L Turner1, Manju L Subramanian1. 1. Department of Ophthalmology, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA. 2. Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA. 3. Department of Veterans Affairs Medical Center, Bedford, MA, USA. 4. VA Boston Healthcare System, Boston, MA, USA. 5. Boston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, MA, USA. 6. Department of Genetics, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA. 7. Department of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland, OH, USA. 8. Department of Pharmacology and Experimental Therapeutics, Veterans Affairs Medical Center, Bedford, MA, USA.
Abstract
BACKGROUND: The eye may serve as source for diagnostic testing for early detection of Alzheimer's disease (AD). Examination of amyloid-β (Aβ) and tau protein content in human vitreous and its correlation to neuro-cognition may improve ocular-based AD detection methods. OBJECTIVE: To evaluate levels of Aβ and tau protein in human vitreous humor and investigate the clinical predictive role of these proteins as early diagnostic markers of AD. METHODS: A prospective, single-center, multi-surgeon cohort study. Vitreous humor samples from 80 eyes were measured quantitatively for Aβ40-42, pTau, and tTau. Linear regression was used to test associations between AD biomarker levels, Mini-Mental State Exam (MMSE), and serum apolipoprotein E (APOE) allele status, with adjustment for age, sex, and education level of patients. RESULTS: Lower MMSE scores were significantly associated with lower levels of vitreous Aβ40 (p = 0.015), Aβ42 (p = 0.0066), and tTau (p = 0.0085), and these biomarkers were not associated with any pre-existing eye conditions. Presence of the ɛ4 allele and the ɛ2 allele approached significance with reduced Aβ40 level (p = 0.053) and increased p-Tau level (p = 0.056), respectively. CONCLUSION: Patients with poor cognitive function have significantly lower vitreous humor levels of AD-related biomarkers Aβ40, Aβ42, and tTau. These biomarkers do not correlate with underlying eye conditions, suggesting their specificity in association with cognitive change. This is the first study to our knowledge to correlate cognition with AD-related proteins in the vitreous humor. Results suggest ocular proteins may have a role for early dementia detection in individuals at risk for AD.
BACKGROUND: The eye may serve as source for diagnostic testing for early detection of Alzheimer's disease (AD). Examination of amyloid-β (Aβ) and tau protein content in human vitreous and its correlation to neuro-cognition may improve ocular-based AD detection methods. OBJECTIVE: To evaluate levels of Aβ and tau protein in humanvitreous humor and investigate the clinical predictive role of these proteins as early diagnostic markers of AD. METHODS: A prospective, single-center, multi-surgeon cohort study. Vitreous humor samples from 80 eyes were measured quantitatively for Aβ40-42, pTau, and tTau. Linear regression was used to test associations between AD biomarker levels, Mini-Mental State Exam (MMSE), and serum apolipoprotein E (APOE) allele status, with adjustment for age, sex, and education level of patients. RESULTS: Lower MMSE scores were significantly associated with lower levels of vitreous Aβ40 (p = 0.015), Aβ42 (p = 0.0066), and tTau (p = 0.0085), and these biomarkers were not associated with any pre-existing eye conditions. Presence of the ɛ4 allele and the ɛ2 allele approached significance with reduced Aβ40 level (p = 0.053) and increased p-Tau level (p = 0.056), respectively. CONCLUSION:Patients with poor cognitive function have significantly lower vitreous humor levels of AD-related biomarkers Aβ40, Aβ42, and tTau. These biomarkers do not correlate with underlying eye conditions, suggesting their specificity in association with cognitive change. This is the first study to our knowledge to correlate cognition with AD-related proteins in the vitreous humor. Results suggest ocular proteins may have a role for early dementia detection in individuals at risk for AD.
Authors: Cecilia S Lee; Eric B Larson; Laura E Gibbons; Aaron Y Lee; Susan M McCurry; James D Bowen; Wayne C McCormick; Paul K Crane Journal: Alzheimers Dement Date: 2018-08-08 Impact factor: 21.566
Authors: Fanni Haapalinna; Merja Kokki; Olli Jääskeläinen; Merja Hallikainen; Seppo Helisalmi; Anne Koivisto; Hannu Kokki; Teemu Paajanen; Janne Penttinen; Maria Pikkarainen; Minna Rautiainen; Hilkka Soininen; Eino Solje; Anne M Remes; Sanna-Kaisa Herukka Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Siwei Liu; Yi-Ting Ong; Saima Hilal; Yng Miin Loke; Tien Y Wong; Christopher Li-Hsian Chen; Carol Y Cheung; Juan Zhou Journal: J Alzheimers Dis Date: 2016-09-06 Impact factor: 4.472
Authors: Bob Olsson; Ronald Lautner; Ulf Andreasson; Annika Öhrfelt; Erik Portelius; Maria Bjerke; Mikko Hölttä; Christoffer Rosén; Caroline Olsson; Gabrielle Strobel; Elizabeth Wu; Kelly Dakin; Max Petzold; Kaj Blennow; Henrik Zetterberg Journal: Lancet Neurol Date: 2016-04-08 Impact factor: 44.182
Authors: Fatmire Berisha; Gilbert T Feke; Clement L Trempe; J Wallace McMeel; Charles L Schepens Journal: Invest Ophthalmol Vis Sci Date: 2007-05 Impact factor: 4.799
Authors: Kelsey E Melah; Sharon Yuan-Fu Lu; Siobhan M Hoscheidt; Andrew L Alexander; Nagesh Adluru; Daniel J Destiche; Cynthia M Carlsson; Henrik Zetterberg; Kaj Blennow; Ozioma C Okonkwo; Carey E Gleason; N Maritza Dowling; Lisa C Bratzke; Howard A Rowley; Mark A Sager; Sanjay Asthana; Sterling C Johnson; Barbara B Bendlin Journal: J Alzheimers Dis Date: 2016 Impact factor: 4.472
Authors: Fabian Höhn; Florian Ta Kretz; Saumil Sheth; S Natarajan; Pankaj Singh; Frank H Koch; Michael J Koss Journal: Clin Ophthalmol Date: 2015-08-13
Authors: Manju L Subramanian; Viha Vig; Jaeyoon Chung; Marissa G Fiorello; Weiming Xia; Henrik Zetterberg; Kaj Blennow; Madeleine Zetterberg; Farah Shareef; Nicole H Siegel; Steven Ness; Gyungah R Jun; Thor D Stein Journal: Alzheimers Res Ther Date: 2020-09-17 Impact factor: 6.982
Authors: Marlies Gijs; Inez H G B Ramakers; Pieter Jelle Visser; Frans R J Verhey; Marjo P H van de Waarenburg; Casper G Schalkwijk; Rudy M M A Nuijts; Carroll A B Webers Journal: Sci Rep Date: 2021-11-22 Impact factor: 4.379